As reported in other types of tumors, IAP proteins, especially XIAP and survivin, were highly expressed in many of the NSCLC cell lines tested in this study, emphasizing that some of NSCLC cell lines overexpress both IAPs and EGFR, suggesting that both oncogenic molecules are suitable targets for the treatment of lung cancer. This evidence concerns the gene BIRC5 and lung carcinoma.